These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7128964)

  • 21. The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects.
    Taylor ML; Stewart GA; Thompson PJ
    Br J Clin Pharmacol; 1993 Mar; 35(3):227-34. PubMed ID: 8471399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Platelet aggregation in diabetes mellitus at various stages of development of retinopathy].
    Titova SI; Gincherman EZ
    Probl Endokrinol (Mosk); 1979; 25(4):6-11. PubMed ID: 471973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pioglitazone inhibits platelet function and potentiates the effects of aspirin: a prospective observation study.
    Mongan J; Mieszczanska HZ; Smith BH; Messing SP; Phipps RP; Francis CW
    Thromb Res; 2012 Jun; 129(6):760-4. PubMed ID: 22225857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet aggregation in human whole blood after chronic administration of aspirin.
    de la Cruz JP; Camara S; Bellido I; Carrasco T; Sanchez de la Cuesta F
    Thromb Res; 1987 Apr; 46(1):133-40. PubMed ID: 3109069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between structure and activity of aspirin-related compounds on the inhibition of in vitro platelet aggregation.
    Dupin JP; Gravier D; Casadebaig F; Boisseau MR; Bernard H
    Farmaco Sci; 1986 Mar; 41(3):205-14. PubMed ID: 3086120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine.
    Chevolet C; Grosdent JC; Reiters GM; Dresse A
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):310-1. PubMed ID: 6817725
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet aggregation related to age in diabetes mellitus.
    Lecrubier C; Scarabin PY; Grauso F; Samama M
    Haemostasis; 1980; 9(1):43-51. PubMed ID: 7351315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex difference in the effect of aspirin on rat platelet aggregation and arachidonic acid metabolism.
    Morikawa M; Kojima T; Inoue M; Tsuboi M
    Jpn J Pharmacol; 1985 Apr; 37(4):317-23. PubMed ID: 3925205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a new anti-inflammatory imidazole derivative, fenflumizole, on platelet aggregation in the rabbit.
    Aono J; Nabata H; Sakai K
    Jpn J Pharmacol; 1986 Dec; 42(4):575-8. PubMed ID: 3100849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study.
    Watala C; Ulicna O; Golanski J; Nocun M; Waczulíková I; Markuszewski L; Drzewoski J
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):113-24. PubMed ID: 16479193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
    Onodera H; Hirata T; Sugawara H; Sugai K; Yoda B; Toyota T; Goto Y
    Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin sensitivity of platelet aggregation in diabetes mellitus.
    Albert SG; Hasnain BI; Ritter DG; Joist JH; Mooradian AD
    Diabetes Res Clin Pract; 2005 Nov; 70(2):195-9. PubMed ID: 15894396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of low-dose acetylsalicylic acid on thrombocytes in health subjects and in patients with coronary heart disease].
    Terres W; Schuster O; Kupper W; Bleifeld W
    Dtsch Med Wochenschr; 1989 Aug; 114(33):1231-6. PubMed ID: 2504574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term ultra-low-dose aspirin therapy and platelet function.
    Chetty N; Atkinson PM; Bradlow BA
    S Afr Med J; 1985 Aug; 68(5):307-9. PubMed ID: 3929399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of low-dose aspirin and specific thromboxane synthetase inhibition on whole blood platelet aggregation and adenosine triphosphate secretion in healthy dogs.
    Grauer GF; Rose BJ; Toolan L; Thrall MA; Colgan SP
    Am J Vet Res; 1992 Sep; 53(9):1631-5. PubMed ID: 1416368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Platelet aggregation in diabetes mellitus in relation to diabetic retinopathy].
    Miralles García JM; Pablo Dávila F; Sánchez Martín S; Alberca Silva I
    Rev Clin Esp; 1980 May; 157(3):183-85. PubMed ID: 7403595
    [No Abstract]   [Full Text] [Related]  

  • 37. Platelet shape change abnormalities in diabetic retinopathy.
    Porta M; Hilgard P; Kohner EM
    Diabetologia; 1980 Mar; 18(3):217-21. PubMed ID: 7372026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preliminary findings on 2 groups of diabetics with regard to platelet aggregation in relation to retinopathy and ultimate relation to antidiabetic therapy].
    Cavaliere R; Giangrandi E; Innocenti M; Parisi R
    Minerva Med; 1978 Jun; 69(28):1923-8. PubMed ID: 662185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro].
    Gorczynska E; James M; Wegrzynowicz R; Masiak M
    Wiad Lek; 1985 Jul; 38(13):920-5. PubMed ID: 3933184
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased platelet thromboxane receptor sensitivity in diabetic patients with proliferative retinopathy.
    Collier A; Tymkewycz P; Armstrong R; Young RJ; Jones RL; Clarke BF
    Diabetologia; 1986 Aug; 29(8):471-4. PubMed ID: 3019811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.